Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details Narrative)

Stockholders' Deficit (Details Narrative) - USD ($)										1 Months Ended		3 Months Ended			9 Months Ended
Stockholders' Deficit (Details Narrative) - USD ($)	Aug. 31, 2020	Jun. 30, 2020	Jun. 16, 2020	May 27, 2020	May 05, 2020	May 04, 2020	Dec. 23, 2019	May 12, 2019	Mar. 27, 2019	Aug. 31, 2020	Sep. 30, 2017	Sep. 30, 2020	Jun. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Jun. 09, 2020	Dec. 31, 2019	Dec. 31, 2018
Common stock shares authorized												10,000,000,000			10,000,000,000			10,000,000,000
Common stock par value												$ 0.0001			$ 0.0001			$ 0.0001
Preferred stock shares authorized												5,000,000			5,000,000
Preferred stock par value												$ 0.01			$ 0.01
Number of common stock issued, value													$ 2,500
Gain on extinguishment of debt												$ 389,864			$ 389,864
Deemed dividend												$ 59,800,000			$ 59,800,000	123,900,000
Debt converted into shares															589,500
Common stock shares issued												1,866,929			1,866,929			964,894
Common stock shares outstanding												1,866,929			1,866,929			964,894
Stock-based compensation																25,950
Interest expenses																9,500,000
Warrants [Member]
Warrants outstanding												335,400,000			335,400,000
Warrant expiration date								Mar. 31, 2022
Fair value of warrants								$ 5,400,000	$ 4,100,000
Interest expenses																9,500,000
2007 Equity Plan [Member]
Stock-based compensation																$ 25,950
Weighted average period															5 years 7 months 6 days
Intrinsic value of options exercisable												$ 0			$ 0
Alcimede LLC [Member] \| Mr. Lagan [Member]
Voting rights percentage				Mr. Lagan and Alcimede LLC, the holders of 50.25% of the total voting power of the Company's voting securities.
Reverse stock split, description				1-for-100 to 1-for-10,000
Exchange Agreement [Member]
Number of shares issued upon conversion, value						$ 250,000
Exchange and Redemption Agreement [Member]
Gain on extinguishment of debt												$ 400,000			400,000
Interest expenses															$ 2,300,000
Series H Preferred Stock [Member]
Preferred stock shares authorized												14,202			14,202			14,202
Preferred stock par value												$ 0.01			$ 0.01			$ 0.01
Preferred stock shares outstanding												10			10			10
Preferred stock, stated value												$ 1,000			$ 1,000
Series F Convertible Preferred Stock [Member]
Preferred stock shares outstanding												1,750,000			1,750,000
Series F Convertible Preferred Stock [Member] \| Genomas, Inc [Member]
Number of common shares issued											1,750,000
Number of common stock issued, value											$ 174,097
Series L Convertible Preferred Stock [Member]
Preferred stock shares outstanding												250,000			250,000
Series M Preferred Stock [Member]
Preferred stock shares authorized												30,000			30,000		30,000	30,000
Preferred stock par value												$ 0.01			$ 0.01		$ 1,000	$ 0.01
Preferred stock shares outstanding												22,000			22,000			0
Debt and accrued interest															$ 22,000,000
Debt description			Regardless of the number of shares of Series M Preferred Stock outstanding and so long as at least one share of Series M Preferred Stock is outstanding, the outstanding shares of Series M Preferred Stock shall have the number of votes, in the aggregate, equal to 51% of all votes entitled to be voted at any meeting of stockholders or action by written consent. Each outstanding share of the Series M Preferred Stock shall represent its proportionate share of the 51% allocated to the outstanding shares of Series M Preferred Stock in the aggregate.
Conversion rate			90.00%
Dividend rate			10.00%
Series M Preferred Stock [Member] \| Mr. Diamantis [Member]
Preferred stock, stated value		$ 0.01											$ 0.01
Gain on extinguishment of debt		$ 18,800,000
Exchange of shares		22,000,000
Deemed dividend												$ 3,200,000			3,200,000
Debt and accrued interest															$ 18,800,000
Series N Preferred Stock [Member]
Preferred stock shares authorized	50,000									50,000		50,000			50,000				50,000
Preferred stock par value	$ 1,000									$ 1,000		$ 0.01			$ 0.01				$ 0.01
Preferred stock shares outstanding												30,304			30,304				0
Dividend rate	10.00%
Debt conversion description	The conversion price is equal to 90% of the lowest VWAP during the 10 trading days immediately prior to the conversion date. Holders of the Series N Preferred Stock are prohibited from converting Series N Preferred Stock into shares of common stock if, as a result of such conversion, the holder, together with its affiliates, would own more than 4.99% (or, upon election of the holder, 9.99%) of the total number of shares of common stock then issued and outstanding. However, any holder may increase or decrease such percentage to any other percentage not in excess of 9.99%, provided that any increase in such percentage shall not be effective until 61 days after notice to the Company.
Debt converted into shares															131
Series N Preferred Stock [Member] \| Exchange and Redemption Agreement [Member]
Number of common stock issued, value										$ 24,200,000
Series H Preferred Stock [Member]
Weighted average common stock price percentage															85.00%
Series K Preferred Stock [Member]
Preferred stock shares authorized												250,000			250,000			250,000
Preferred stock par value												$ 0.01			$ 0.01			$ 0.01
Preferred stock shares outstanding												0			0			250,000
Series K Preferred Stock [Member] \| Exchange Agreement [Member] \| Alcimede LLC [Member]
Number of shares issued upon conversion, value					$ 250,000		$ 250,000
Cumulative dividends percentage							8.00%
Series J Preferred Stock [Member] \| Exchange Agreement [Member] \| Alcimede LLC [Member]
Number of shares issued upon conversion, value							$ 250,000
Series L Preferred Stock [Member]
Preferred stock shares authorized												250,000			250,000			250,000
Preferred stock par value												$ 0.01			$ 0.01			$ 0.01
Preferred stock shares outstanding												250,000			250,000			0
Series L Preferred Stock [Member] \| Exchange Agreement [Member] \| Alcimede LLC [Member]
Number of shares issued upon conversion, value					$ 250,000
Series I-1 and Series I-2 Preferred Stock [Member] \| Exchange and Redemption Agreement [Member]
Preferred stock shares authorized	30,435.52									30,435.52
Number of common stock issued, value										$ 6,257,616
Deemed dividend															$ 3,700,000
Series I-2 Preferred Stock [Member]
Preferred stock shares outstanding	30,435.52									30,435.52
Number of common shares issued															313,000
Number of shares converted															236.30	982.101